ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Zheng Li
Matched on ORCID iD 0009-0004-6313-226X; OpenAlex author ID A5100423724. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2024: 2 papers
Papers 2
- SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. Co-author DOI 10.1038/s41401-023-01199-z↗
- Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective c… Co-author DOI 10.1186/s12957-023-03277-2↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianjun Yu · 2 shared papers, 2024 · strength 0.40
- Paper Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resecta… DOI 10.1186/s12957-023-03277-2↗
- Paper SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. DOI 10.1038/s41401-023-01199-z↗
- Shunrong Ji · 2 shared papers, 2024 · strength 0.40
- Paper Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resecta… DOI 10.1186/s12957-023-03277-2↗
- Paper SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. DOI 10.1038/s41401-023-01199-z↗
- Xiaowu Xu · 1 shared paper, 2024 · strength 0.20
- Qifeng Zhuo · 1 shared paper, 2024 · strength 0.20
- Wenyan Xu · 1 shared paper, 2024 · strength 0.20
- Mengqi Liu · 1 shared paper, 2024 · strength 0.20
- Wensheng Liu · 1 shared paper, 2024 · strength 0.20
- Hai-di Chen · 1 shared paper, 2024 · strength 0.20
- Ye Zeng · 1 shared paper, 2024 · strength 0.20
- Haifeng Hu · 1 shared paper, 2024 · strength 0.20
- Chenjie Zhou · 1 shared paper, 2024 · strength 0.20
- Xiaowu Xu · 1 shared paper, 2024 · strength 0.20
- Yi Qin · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.